rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert S. Radie

Director

Company insider

Files Form 4 as: Director, Rockwell Medical; Director, Paratek Pharmaceuticals; Principal Financial Officer, Zyla Life Sciences.

Every Form 4 they filed

In numbers

Trades disclosed
84
Buys
0
Sells
27
Bought
$0
Sold
$1.9M
Companies
3
Companies where not an officer
2
First trade
11 Feb 2014
Last trade
1 Jul 2026
Last filed
6 Jul 2026

Companies traded

Where they are an officer
Zyla Life SciencesDirector, Officer · last 31 Dec 20190 buys · 25 sells
Everywhere else they filed: board seats, 10% stakes, other companies
RMTI Rockwell MedicalDirector · Biotechnology · last 1 Jul 20260 buys · 0 sells
Paratek PharmaceuticalsDirector · last 21 Sep 20230 buys · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Jul 2026filed 6 Jul 2026RMTI Rockwell MedicalBiotechnologySEC FORM 4 Code A—9,633 at $0.00filing
1 Jul 2026filed 6 Jul 2026RMTI Rockwell MedicalBiotechnologySEC FORM 4 Code A—9,633 at $0.00filing
20 May 2025filed 21 May 2025RMTI Rockwell MedicalBiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
21 May 2024filed 23 May 2024RMTI Rockwell MedicalBiotechnologySEC FORM 4 Code A—36,111 at $0.00filing
21 Sep 2023filed 21 Sep 2023Paratek Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—7,000filing
21 Sep 2023filed 21 Sep 2023Paratek Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—7,000filing
21 Sep 2023filed 21 Sep 2023Paratek Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—5,000filing
21 Sep 2023filed 21 Sep 2023Paratek Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—5,000filing
21 Sep 2023filed 21 Sep 2023Paratek Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—6,000filing
21 Sep 2023filed 21 Sep 2023Paratek Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—12,000filing
21 Sep 2023filed 21 Sep 2023Paratek Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—20,000filing
21 Sep 2023filed 21 Sep 2023Paratek PharmaceuticalsSEC FORM 4 Code D—53,000filing
21 Sep 2023filed 21 Sep 2023Paratek PharmaceuticalsSEC FORM 4 Code D—20,000filing
23 May 2023filed 25 May 2023RMTI Rockwell MedicalBiotechnologySEC FORM 4 Code A—24,715 at $0.00filing
8 Feb 2023filed 9 Feb 2023Paratek PharmaceuticalsSEC FORM 4 Code A—20,000 at $0.00filing
7 Jun 2022filed 9 Jun 2022RMTI Rockwell MedicalBiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
16 Feb 2022filed 18 Feb 2022Paratek PharmaceuticalsSEC FORM 4 Code A—20,000 at $0.00filing
17 Jun 2021filed 22 Jun 2021RMTI Rockwell Medicaloption or derivative · BiotechnologySEC FORM 4 Code A—72,857 at $0.00filing
17 Jun 2021filed 22 Jun 2021RMTI Rockwell MedicalBiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
18 Feb 2021filed 22 Feb 2021Paratek Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—7,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed27

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.